Clinical Trial Update: Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection [EARLY_Phase 1]

View source ↗

Summary

An early-phase, adjuvant trial testing a neoantigen vaccine plus capecitabine after surgical resection for intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Neoantigen vaccine

Snippet

Sponsor: Yongyi Zeng | Conditions: Intrahepatic Cholangiocarcinoma | EARLY_Phase 1 | Status: RECRUITING